Akèy › Kansè poumon › New York › Queens
Etid klinik pou Kansè poumon nan Queens, NY
22 etid pou Kansè poumon ap chèche patisipan nan sit nan ak bò kote Queens (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi lwen
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Ap rekriteFaz 3
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi lwen
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Queens Hospital Center, Jamaica · 2 mi lwen
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Ap rekriteFaz 3
- Optum Medical Care, PC, Westbury · 14 mi lwen
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Ap rekriteFaz 2
- MSK Nassau, Uniondale · 13 mi lwen
A Registry for People With Lung Cancer
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi lwen
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Ap rekriteFaz 2/3
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi lwen
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Ap rekriteFaz 1
- NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola · 11 mi lwen
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Ap rekriteFaz 3
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9 mi lwen
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi lwen
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Clinical Research Alliance, Westbury · 14 mi lwen
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Ap rekriteFaz 1
- NYU Langone Health - Long Island, Mineola · 11 mi lwen
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Ap rekriteFaz 3
- Northwell Health/R.J. Zuckerberg Cancer Center, Lake Success · 9 mi lwen
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi lwen
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Ap rekriteFaz 3
- NYU Langone Hospital - Long Island, Mineola · 11 mi lwen
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
A Study of Lung Cancer Risk
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi lwen
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Ap rekrite
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre · 10 mi lwen
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Ap rekriteFaz 1/2
- Clinical Research Alliance, Westbury · 14 mi lwen
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau, Rockville Centre · 10 mi lwen
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Memorial Sloan Kettering Nassau, Uniondale · 13 mi lwen
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Ap rekriteEtid obsèvasyon
- Northwell Health/Center for Advanced Medicine, Lake Success · 9 mi lwen
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Hempstead · 12 mi lwen
Etid Kansè poumon nan lòt vil
- Houston, TX78 etid
- Boston, MA62 etid
- New York City, NY60 etid
- Los Angeles, CA45 etid
- Arlington, VA41 etid
- Washington, DC41 etid
- Chicago, IL41 etid
- Nashville, TN40 etid
- Baltimore, MD40 etid
- St. Louis, MO39 etid
- Columbus, OH37 etid
- Philadelphia, PA36 etid
Lòt etid nan Queens
- Kansè nan tete64 etid
- Kansè Poumon ki pa ti selil49 etid
- Kansè kolorektal31 etid
- Kansè Metastatik28 etid
- Kansè ovè28 etid
- Kansè pwostat27 etid
- Kansè (tout kalite)26 etid
- Kansè Endomèt25 etid
- Leksemi mieloïd egi21 etid
- Myelom Miltip20 etid
- Kansè pankreyas20 etid
- Karsinòm selil skuamèz tèt ak kou20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.